Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

485 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomized, Placebo-controlled Study.
Mall MA, Brugha R, Gartner S, Legg J, Moeller A, Mondejar-Lopez P, Prais D, Pressler T, Ratjen F, Reix P, Robinson PD, Selvadurai H, Stehling F, Ahluwalia N, Arteaga-Solis E, Bruinsma BG, Jennings M, Moskowitz SM, Noel S, Tian S, Weinstock TG, Wu P, Wainwright CE, Davies JC. Mall MA, et al. Among authors: ratjen f. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1361-1369. doi: 10.1164/rccm.202202-0392OC. Am J Respir Crit Care Med. 2022. PMID: 35816621 Free PMC article. Clinical Trial.
Endothelial nitric oxide synthase variants in cystic fibrosis lung disease.
Grasemann H, Storm van's Gravesande K, Buscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Am J Respir Crit Care Med. 2003 Feb 1;167(3):390-4. doi: 10.1164/rccm.200202-155OC. Epub 2002 Aug 15. Am J Respir Crit Care Med. 2003. PMID: 12406848
Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F; Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group. Paul K, et al. Among authors: ratjen f. Am J Respir Crit Care Med. 2004 Mar 15;169(6):719-25. doi: 10.1164/rccm.200307-959OC. Epub 2003 Dec 18. Am J Respir Crit Care Med. 2004. PMID: 14684561 Clinical Trial.
Inhalation of Moli1901 in patients with cystic fibrosis.
Grasemann H, Stehling F, Brunar H, Widmann R, Laliberte TW, Molina L, Döring G, Ratjen F. Grasemann H, et al. Among authors: ratjen f. Chest. 2007 May;131(5):1461-6. doi: 10.1378/chest.06-2085. Chest. 2007. PMID: 17494794 Clinical Trial.
Update in cystic fibrosis 2008.
Ratjen F. Ratjen F. Am J Respir Crit Care Med. 2009 Mar 15;179(6):445-8. doi: 10.1164/rccm.200812-1927UP. Am J Respir Crit Care Med. 2009. PMID: 19264980 No abstract available.
The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN, Ratjen F. Bendiak GN, et al. Among authors: ratjen f. Semin Respir Crit Care Med. 2009 Oct;30(5):587-95. doi: 10.1055/s-0029-1238917. Epub 2009 Sep 16. Semin Respir Crit Care Med. 2009. PMID: 19760546 Review.
485 results